Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria

J Am Acad Dermatol. 2012 Dec;67(6):1383-4. doi: 10.1016/j.jaad.2012.02.006.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Anion Exchange Resins / administration & dosage*
  • Cholestyramine Resin / administration & dosage*
  • Humans
  • Porphyria, Hepatoerythropoietic / drug therapy*
  • Treatment Failure

Substances

  • Anion Exchange Resins
  • Cholestyramine Resin